tandfonline.com/doi/pdf/10....
ROS vs. metastases. In many types of tumors including prostate
cancer, melanoma and breast cancer, the increased metastatic ability
of tumor cells is positively related to their intracellular ROS level.
Exogenously administration of ROS would enhance certain stages
of metastatisis,
29
while anti-oxidant treatment could attenuate
metastatic progress.
30
Even surgical procedures, a primary option
for treating tumors, can lead to the increased growth of metastatic
tumors by ROS generation.
13
Possible mechanisms involve aber-
rant expression of integrins and MMPs and suppression of anoikis,
as indicated by in vitro studies.
15
Intriguingly, Ishikawa K. and his
colleagues recently have provided direct evidence to confirm the
causative relationship between ROS and tumor metastasis. After
replaced with mitochondria DNA (mtDNA) derived from a highly
metastatic mouse tumor cell line, an originally poorly metastatic
cell line acquires the metastatic potential. The transferred mtDNA
contain mutations producing a deficiency in respiratory complex I
activity and are associated with overproduction of ROS. Pretreatment
of the highly metastatic tumor cells with ROS scavengers suppresses
their metastatic potential in mice.